Money Bills Favor NIH, Squeeze NSF

WASHINGTON—The status of research funding bills for 1988, as Congress returns from its month-long summer break, reflects the difference between word and deed in politics. In January President Reagan proposed a federal budget that called for a healthy increase for NSF, selective increases for R&D at NASA, and a sharp reduction in funding for NIH. Eight months later, as Congress approaches its October 1 deadline to appropriate money for the 1988 fiscal year, the opposite appears more like

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—The status of research funding bills for 1988, as Congress returns from its month-long summer break, reflects the difference between word and deed in politics.

In January President Reagan proposed a federal budget that called for a healthy increase for NSF, selective increases for R&D at NASA, and a sharp reduction in funding for NIH. Eight months later, as Congress approaches its October 1 deadline to appropriate money for the 1988 fiscal year, the opposite appears more likely to occur—a substantial increase for NIH, and a possible freeze in the NSF and NASA budgets.

Despite all the rhetoric about the need to revitalize the nation’s space program and the importance of basic research in competing with our economic adversaries, the two agencies most responsible for achieving those goals are emerging as the edd men out in the perennial congressional search for ways to reduos the federal deficit. And NIH, which ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo